Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.
C BonifatiS LemboA G RichettaMarco RomanelliF SatolliM CorazzaLaura AtzoriC LasagniC PotenzaPaola SavoiaF BardazziV G Di LerniaL BianchiG FabbrociniC GiofrèL ZichichiClaudio GuarneriS PallottaMaria-Concetta FargnoliF LoconsoleA OffidaniMartina BurlandoStefano PiasericoKetty PerisM PapiniC G CarreraAntonio CostanzoFrancesca PrignanoMaria Rita BongiornoP DapavoLuca StingeniM DoniniG MicaliFranco RongiolettiGiuseppe StincoT GramicciaG CantiniGiuseppe ArgenzianoPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Guselkumab, showing to be effective and safe in treating FP and GP, may be a valid therapeutic option for patients with psoriasis localized in these difficult-to-treat areas.